As of 2026-09-15, the Relative Valuation of Flexion Therapeutics Inc (FLXN) is (96.59) USD. This relative valuation is based on P/E multiples. With the latest stock price at 24.62 USD, the upside of Flexion Therapeutics Inc based on Relative Valuation is -492.3%.
The range of the Relative Valuation is (94.88) - (102.50) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 16.9x - 19.8x | 18.2x |
| Forward P/E multiples | 15.5x - 18.3x | 16.3x |
| Fair Price | (94.88) - (102.50) | (96.59) |
| Upside | -485.4% - -516.3% | -492.3% |
| Date | P/E |
| 2026-09-11 | -4.39 |
| 2026-09-10 | -4.38 |
| 2026-09-09 | -4.41 |
| 2026-09-08 | -4.42 |
| 2026-09-04 | -4.42 |
| 2026-09-03 | -4.43 |
| 2026-09-02 | -4.42 |
| 2026-09-01 | -4.41 |
| 2026-08-31 | -4.43 |
| 2026-08-28 | -4.42 |
| 2026-08-27 | -4.43 |
| 2026-08-26 | -4.43 |
| 2026-08-25 | -4.46 |
| 2026-08-24 | -4.45 |
| 2026-08-21 | -4.45 |
| 2026-08-20 | -4.44 |
| 2026-08-19 | -4.45 |
| 2026-08-18 | -4.44 |
| 2026-08-17 | -4.44 |
| 2026-08-14 | -4.45 |
| 2026-08-13 | -4.45 |
| 2026-08-12 | -4.44 |
| 2026-08-11 | -4.44 |
| 2026-08-10 | -4.43 |
| 2026-08-07 | -4.44 |
| 2026-08-06 | -4.43 |
| 2026-08-05 | -4.44 |
| 2026-08-04 | -4.44 |
| 2026-08-03 | -4.42 |
| 2026-07-31 | -4.41 |
| 2026-07-30 | -4.40 |
| 2026-07-29 | -4.37 |
| 2026-07-28 | -4.40 |
| 2026-07-27 | -4.39 |
| 2026-07-24 | -4.42 |
| 2026-07-23 | -4.42 |
| 2026-07-22 | -4.44 |
| 2026-07-21 | -4.45 |
| 2026-07-20 | -4.45 |
| 2026-07-17 | -4.45 |
| 2026-07-16 | -4.46 |
| 2026-07-15 | -4.46 |
| 2026-07-14 | -4.45 |
| 2026-07-13 | -4.44 |
| 2026-07-10 | -4.45 |
| 2026-07-09 | -4.46 |
| 2026-07-08 | -4.45 |
| 2026-07-07 | -4.45 |
| 2026-07-06 | -4.46 |
| 2026-07-02 | -4.45 |